+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Drugs By Therapeutic Area Market Research Reports

Scars - Pipeline Insight, 2024 - Product Thumbnail Image

Scars - Pipeline Insight, 2024

  • Clinical Trials
  • November 2024
  • 60 Pages
  • Global
From
Respiratory Syncytial Virus (RSV) - Pipeline Insight, 2024 - Product Thumbnail Image

Respiratory Syncytial Virus (RSV) - Pipeline Insight, 2024

  • Clinical Trials
  • November 2024
  • 180 Pages
  • Global
From
Schizophrenia - Pipeline Insight, 2024 - Product Thumbnail Image

Schizophrenia - Pipeline Insight, 2024

  • Clinical Trials
  • November 2024
  • 180 Pages
  • Global
From
Niemann-Pick disease - Pipeline Insight, 2024 - Product Thumbnail Image

Niemann-Pick disease - Pipeline Insight, 2024

  • Clinical Trials
  • November 2024
  • 60 Pages
  • Global
From
Stargardt Disease (STGD) - Pipeline Insight, 2024 - Product Thumbnail Image

Stargardt Disease (STGD) - Pipeline Insight, 2024

  • Clinical Trials
  • November 2024
  • 240 Pages
  • Global
From
Homocystinuria - Pipeline Insight, 2024 - Product Thumbnail Image

Homocystinuria - Pipeline Insight, 2024

  • Drug Pipelines
  • November 2024
  • 60 Pages
  • Global
From
NLRP3 Protein Inhibitors - Pipeline Insight, 2024 - Product Thumbnail Image

NLRP3 Protein Inhibitors - Pipeline Insight, 2024

  • Drug Pipelines
  • November 2024
  • 80 Pages
  • Global
From
Graves' Disease - Pipeline Insight, 2024 - Product Thumbnail Image

Graves' Disease - Pipeline Insight, 2024

  • Drug Pipelines
  • November 2024
  • 60 Pages
  • Global
From
Muscarinic Acetylcholine Receptor M1 Antagonists - Pipeline Insight, 2024 - Product Thumbnail Image

Muscarinic Acetylcholine Receptor M1 Antagonists - Pipeline Insight, 2024

  • Drug Pipelines
  • November 2024
  • 60 Pages
  • Global
From
Peripheral Arterial Disease (PAD)- Pipeline Insight, 2024 - Product Thumbnail Image

Peripheral Arterial Disease (PAD)- Pipeline Insight, 2024

  • Clinical Trials
  • November 2024
  • 80 Pages
  • Global
From
Ischemic Stroke - Pipeline Insight, 2024 - Product Thumbnail Image

Ischemic Stroke - Pipeline Insight, 2024

  • Clinical Trials
  • November 2024
  • 180 Pages
  • Global
From
Pompe Disease - Pipeline Insight, 2024 - Product Thumbnail Image

Pompe Disease - Pipeline Insight, 2024

  • Clinical Trials
  • November 2024
  • 80 Pages
  • Global
From
Lupus Nephritis - Pipeline Insight, 2024 - Product Thumbnail Image

Lupus Nephritis - Pipeline Insight, 2024

  • Clinical Trials
  • November 2024
  • 80 Pages
  • Global
From
Dementia Associated With Alzheimer's Disease - Pipeline Insight, 2024 - Product Thumbnail Image

Dementia Associated With Alzheimer's Disease - Pipeline Insight, 2024

  • Clinical Trials
  • November 2024
  • 240 Pages
  • Global
From
Yellow Fever - Pipeline Insight, 2024 - Product Thumbnail Image

Yellow Fever - Pipeline Insight, 2024

  • Clinical Trials
  • November 2024
  • 60 Pages
  • Global
From
Diabetes - Pipeline Insight, 2024 - Product Thumbnail Image

Diabetes - Pipeline Insight, 2024

  • Clinical Trials
  • November 2024
  • 450 Pages
  • Global
From
Non-cystic fibrosis bronchiectasis - Pipeline Insight, 2024 - Product Thumbnail Image

Non-cystic fibrosis bronchiectasis - Pipeline Insight, 2024

  • Drug Pipelines
  • November 2024
  • 60 Pages
  • Global
From
Cushing Syndrome - Pipeline Insight, 2024 - Product Thumbnail Image

Cushing Syndrome - Pipeline Insight, 2024

  • Drug Pipelines
  • November 2024
  • 60 Pages
  • Global
From
Type 2 Diabetes - Pipeline Insight, 2024 - Product Thumbnail Image

Type 2 Diabetes - Pipeline Insight, 2024

  • Drug Pipelines
  • November 2024
  • 240 Pages
  • Global
From
Complement Inhibitors - Pipeline Insight, 2024 - Product Thumbnail Image

Complement Inhibitors - Pipeline Insight, 2024

  • Drug Pipelines
  • November 2024
  • 180 Pages
  • Global
From
Loading Indicator

The Drugs by Therapeutic Area market is a segment of the pharmaceutical industry that focuses on the development and sale of drugs for specific medical conditions. These drugs are designed to treat a wide range of diseases, from cancer to mental health disorders. Companies in this market typically specialize in one or more therapeutic areas, such as oncology, neurology, or cardiology. They develop drugs that target specific medical conditions and then market them to healthcare providers and patients. Companies in this market include Pfizer, Merck, Novartis, GlaxoSmithKline, and Sanofi. Show Less Read more